The ultimate aim is to contribute to the development of a vaccine.
Patients and UCLH representatives met in the latest of our remote PPI sessions.
UCLH staff are part of a study looking at rates of Covid-19 infection among healthcare workers.
UCLH is taking part in two global clinical trials of an antiviral drug for COVID-19.
The trial has an ‘adaptive’ design where new therapies can be added to the study over time.
The ISARIC-4C study aims to provide an agile research response to infectious disease outbreaks.
Research looking at why coronavirus affects people differently has been featured on Channel 4 News.
Patients and members of the public joined a Zoom call today to start discussing how best to approach patient and public involvement in research during the Covid-19 pandemic.
The initiative encourages continued working and contact during the pandemic.
UCL Partners Academic Health Sciences Centre (AHSC) n redesignated an AHSC by NIHR and NHS England for the next five years.
UCL, UCLH and Formula One developed the device to support the global response to Covid-19.
9 studies of COVID-19 are already open at UCLH with over 30 study being processed.
Researchers have found a simple blood test can check for more than 50 types of cancer. Investigators involved in the study including researchers from UCL hope that their findings bring them one step nearer a multi-cancer screening test that can be used across populations. Detection of cancers before
The breathing aid for Covid-19 patients was adapted by UCL, UCLH and Mercedes-AMG HPP.
A UCL study will look at the effects of social distancing and self-isolation.